As a typical chronic disease, diabetes has been attracting much attention. At present, there are 140 million diabetic patients in China. With the continuous development of big data, artificial intelligence (AI) and digital therapeutics, diabetes diagnosis and treatment and management are gradually moving towards digitalization and intelligence.
The 2nd AGP&DTx Summit Forum, hosted by the National Innovation Center for High-Performance Medical Devices and the China Dynamic Glucose Atlas and Digital Therapeutics R&D Center (hereinafter referred to as the China AGP&DTx R&D Center), and co-organized by Yimaitong and Shenzhen Silicon-based Bionic Technology Co., Ltd., will be held in Shenzhen on July 5.
Conference Name: The 2nd AGP&DTx Summit Forum
Venue: Hilton Shenzhen Shekou Nanhai Hotel
Meeting time: July 5, 2024
With the theme of "Focusing on the Combination of AGP and Digital Intelligent Management of Diabetes and Discussing Its Application in the Medical Field", this forum was led by Professor Ji Linong, the initiator of China AGP&DTx R&D Center and Professor of Peking University People's Hospital, and invited a number of authoritative experts in the field of endocrinology from Slovenia, Australia, Serbia, Turkey and Algeria to come to the scene to discuss the application of CGM technology, AGP and digital intelligent management of diabetes and other disciplines and fields.
China is the country with the largest number of diabetic patients in the world, and in the face of 140 million diabetic patients, as well as the low control rate and high incidence of complications, how to realize personalized diabetes management and improve management efficiency is an important topic for the medical industry to continuously explore solutions.
With the rapid development of big data, artificial intelligence (AI) and digital therapeutics, diabetes management has also ushered in an era of innovation. The integration of digital management tools has made the diagnosis and treatment and management of diabetes mellitus move towards digitalization and intelligence, and greatly improved the efficiency and effect of diagnosis and treatment.
Therefore, during this conference, experts at home and abroad will conduct special interviews on "digital intelligence of diabetes", and conduct in-depth exchanges and discussions on important topics such as AGP consensus, CGM data of 70,000 Chinese people, artificial pancreas system, and digital intelligent health management.
If you want to know more about the latest information of this forum, please follow the WeChat official account of "Yimaitongtang Doctor" below for details, or scan the QR code below to make an appointment to watch, and work with domestic and foreign experts to explore new technologies for digital and intelligent management of diabetes, support the application of clinical decision-making in diabetes, and jointly promote the development of digital and intelligent management of diabetes!
The QR code of the WeChat public account of Yimaitong Sugar Doctor scans the live QR code to make an appointment to watch
Meeting schedule (subject to the meeting schedule of the day):
Medical Sugar
As an intelligent out-of-hospital chronic disease management platform for clinicians, it covers nearly 100 clinical guidelines/high-evidence-level literature and evidence-based diagnosis and treatment pathways, which can help doctors view the continuous and complete blood glucose data of patients wearing CGM equipment at any time, understand the patient's diet, exercise, and medication, provide diagnosis and treatment reference for diabetes intervention, realize individualized and scientific patient management outside the hospital, and improve management efficiency. Welcome to follow the WeChat public account of "Yimaitongtang Doctor" for details.
END